Study of Vimseltinib for Tenosynovial Giant Cell Tumor

Clinical trial NCT05059262 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05059262
Sponsor: Deciphera Pharmaceuticals, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Tenosynovial Giant Cell Tumor Pigmented Villonodular Synovitis Giant Cell Tumor of Tendon Sheath Tenosynovial Giant Cell Tumor, Diffuse Tenosynovial Giant Cell Tumor, Localized

Start date: 2021-10-14
Primary completion: 2023-08-10
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.